claudia.gentile
@claudiagentile_
Postdoc in the Kadoch lab at Dana-Farber Cancer Institute. Interested in epigenetic gene regulation and cell signalling in development and disease.
A study in @Cancer_Cell, led by Matthew Oser, MD, PhD (@Oser_Lab) & Cigall Kadoch, PhD (@CKadoch) at @danafarber identify SWI/SNF inhibitors as a potential targeted treatment for POU2F3-positive small cell lung cancer, accounting for 12% of cases. Study ▶️ ms.spr.ly/6016lRrkI
New study by Cigall Kadoch, PhD (@CKadoch) @DanaFarber reveals the sequence-specific contributions of intrinsically disordered proteins known as IDRs, which are implicated in cancer. @Cell ms.spr.ly/60109oP6O
Featured in @TheScientistLLC, research in lung cancer cell lines co-led by @DanaFarber's Cigall Kadoch, PhD ( @CKadoch), found that chromatin remodeling underlies one type of osimertinib resistance. ms.spr.ly/60179YXNh
I am honoured to have received the 2023 Next Generation of Scientists Award from the #CancerResearchSociety to support my transition to an independent academic position! #postdoc #CanadianCancerResearch
🏆🌟 Congratulations to the 5 recipients of our 2023 Next Generation of Scientists Award! 🔬 👩🔬👨🔬 ✨Together, let’s invest in the future of research to outsmart cancer! 💪 👉To learn more: loom.ly/PdNBpsE #CancerResearchSociety #CancerResearch #OutsmartCancer
🏆🌟 Félicitations aux 5 récipiendaires de notre Bourse pour la relève scientifique 2023 ! 🔬 👩🔬👨🔬 ✨Ensemble, investissons dans l'avenir de la recherche pour déjouer le cancer ! 💪 👉Pour en savoir plus : loom.ly/45s4PG0 #SocietedeRecherchesurleCancer #RechercheCancer
Today Cell, Cancer Cell and Cell Reports Medicine are pleased to publish the 1st wave of Pan-#Cancer multiomics papers looking at over 1000 patients across 10 #tumor types from @theNCI Clinical Proteomic Tumor Analysis Consortium #CPTAC (1/n) @Cancer_Cell @CellRepMed #openaccess
"This study has revealed a new vulnerability of a subset of lung #adenocarcinomas that have become resistant to standard-of-care targeted therapies,” said Dr. Katerina Politi @politikaterina. yalecancercenter.org/news-article/r… @SmilowCancer @YaleMed @YNHH @yalepathology @Cancer_Cell
Online Now: Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer dlvr.it/StCZzv
The @CIHR_ICR is sponsoring Canada’s participation on a new joint transnational call with the EU, the ERA-NET TRANSCAN-3 – which is focused on translational research on cancer epigenomics transcan.eu/news-and-resou… Call Launch: May 9th 2023 Pre-proposal deadline: July 2023
📢SAVE THE DATE! 👉JTC2023 International Info Day and Networking Event "Translational Research on Cancer Epigenetics" 📆16 May 2023 Register👇 …jtc2023-international-info.b2match.io/signup 🔜 JTC2023 Call Launch: 9 May 2023 Full list of funding organisations: transcan.eu/news-and-resou… #funding #cancer
Happy to see our work on #Tcells #CART out today in @MolecularCell! Great collaboration with my good friend and colleague, @iannisaifantis1 as we worked out the role for #BAFcomplexes in mediating T cell #exhaustion. cell.com/molecular-cell…
Exciting new findings from our @kadochlab @DanaFarber @harvardmed @HHMINEWS regarding the role for #chromatin remodelers in viral infection! This was a terrific collaboration with the @WilenLab @YaleMed ! Congrats, @ajinkyapatil00 and @JinWei0911 on this beautiful work!
🎆 ONLINE TODAY @NatureGenet 📰 Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection 👫 @WilenLab @CKadoch @kadochlab @JinWei0911 @ajinkyapatil00 and team 👇🏻 go.nature.com/3T61AAL
Please register now. There are many short and flash talks that will be selected.
REGISTER NOW! 📝 12th Conference on Signalling in normal and Cancer Cells in Banff @JF_CoteLab @joneslabguelph @MikeGoldVan @ircm_mtl @tfri_research @MarathonOfHope - mailchi.mp/80314144fe8a/r…